Christopher Daugherty to Feasibility Studies
This is a "connection" page, showing publications Christopher Daugherty has written about Feasibility Studies.
Connection Strength
0.041
-
Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998 Jul; 16(7):2305-12.
Score: 0.030
-
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61.
Score: 0.011